Action Collaborative on Combatting Substance Use and Opioid Crises

Caring for Patients with Chronic Pain: Perspectives from Clinicians | Listening Session

March 10, 2020

3:30 PM - 5:00 PM (EDT)

Past

About

Background

The Action Collaborative on Countering the U.S. Opioid Epidemic conducted a series of listening sessions to better understand the state of chronic pain management, as experienced by different end-user and stakeholder groups. An additional aim of the listening sessions is to bring greater awareness to any intended and unintended consequences of recent changes to opioid prescribing guidelines and related metrics, as they pertain to the delivery, access, and coordination of chronic pain management and care.

About this session

This listening session is the second part of the series and serves as a complement to the previous session, which focused on the experiences of those living with chronic pain. The purpose of this listening session was to focus on the perspectives and experiences of clinicians caring for patients with chronic, non-cancer pain. Our hope is to better understand the diversity and complexity of chronic pain care across the health system and to elucidate existing practice and system-level gaps in chronic pain management.

This event took place as a live listening session, during which panelists responded to 5 discussion questions.

There is an opportunity for the audience to participate by providing their written responses to the panelist discussion questions througha participation form.

Panelists:

Gary L. LeRoy, MD, FAAFP, Family Physician and President American Academy of Family Physicians
Tripp Logan, PharmD, Clinical Pharmacist and Chief Operating Officer of the Enhanced Service Pharmacy Alliance
Charles P. Reznikoff, MD, FACP, Addiction Medicine Specialist Hennepin Healthcare
Mark D. Sullivan, MD, PhD, Psychiatrist UWMC Center for Pain Relief and Regional Heart Center
Matt Tierney, MS, NP, FAAN, Nurse Practicioner, Clinical Professor at UC San Francisco School of Nursing, and Clinical Director of Substance Use Treatment and Education for the Ofice of Population Health at UC San Francisco Health

Listening Session Questions for Discussion

What successes or challenges have you had in providing care to patients with pain?
How have prescribing guidelines for prescribing/dispensing medications/opioids for pain positively impacted the people in your care? How have they negatively impacted the people in your care?
How have prescribing guidelines for prescribing/dispensing medications/opioids for pain positively impacted your practice? How have they negatively influenced your daily clinical practice?
Describe any intended or unintended consequences you have experienced from policies/regulations/payer requirements based on opioid prescribing guidelines and provide recommendations for addressing them.
If you had a “magic wand,” what would you change in the health system to improve care for patients with pain?

What it will inform

The session and content gathered will inform the creation of a person-centered pain management journey map—a visual illustration of a chronic pain management journey—that will serve to accelerate the uptake of a range of pain treatments by outlining approaches to effective communication that lead to strong clinical relationships and optimal quality of life for people with pain.

Disclaimer

The views expressed in this listening session are those of the participants and not necessarily of the participants’ organizations, the National Academy of Medicine (NAM), or the National Academies of Sciences, Engineering, and Medicine (the National Academies.)

Contact

Aisha Salman

opioidcollaborative@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webinar

Caring for Patients with Chronic Pain: Perspectives from Clinicians

March 10, 2020

3:30 PM - 5:30 PM (EDT)

Past

About

Background

The Action Collaborative on Countering the U.S. Opioid Epidemic is conducting a series of listening sessions to better understand the state of chronic pain management, as experienced by different end-user and stakeholder groups. An additional aim of the listening sessions is to bring greater awareness to any intended and unintended consequences of recent changes to opioid prescribing guidelines and related metrics, as they pertain to the delivery, access, and coordination of chronic pain management and care.

About this session

This listening session is the second part of the series and serves as a complement to the previous session, which focused on the experiences of those living with chronic pain. The purpose of this listening session is to focus on the perspectives and experiences of clinicians caring for patients with chronic, non-cancer pain. Our hope is to better understand the diversity and complexity of chronic pain care across the health system and to elucidate existing practice and system-level gaps in chronic pain management.

This event will be taking place as a live listening session, during which panelists will respond to 5 discussion questions.

In order to meet the goals for this listening session and dedicate appropriate time for our panelists to share their experiences, there will not be an opportunity for live questions and answers.

There will, however, be an opportunity for the audience to participate by providing their written responses to the panelist discussion questions througha participation form.

Panelists:

Gary L. LeRoy, MD, FAAFP, Family Physician and President American Academy of Family Physicians
Tripp Logan, PharmD, Clinical Pharmacist and Chief Operating Officer of the Enhanced Service Pharmacy Alliance
Charles P. Reznikoff, MD, FACP, Addiction Medicine Specialist Hennepin Healthcare
Mark D. Sullivan, MD, PhD, Psychiatrist UWMC Center for Pain Relief and Regional Heart Center
Matt Tierney, MS, NP, FAAN, Nurse Practicioner, Clinical Professor at UC San Francisco School of Nursing, and Clinical Director of Substance Use Treatment and Education for the Ofice of Population Health at UC San Francisco Health

Listening Session Questions for Discussion

What successes or challenges have you had in providing care to patients with pain?
How have prescribing guidelines for prescribing/dispensing medications/opioids for pain positively impacted the people in your care? How have they negatively impacted the people in your care?
How have prescribing guidelines for prescribing/dispensing medications/opioids for pain positively impacted your practice? How have they negatively influenced your daily clinical practice?
Describe any intended or unintended consequences you have experienced from policies/regulations/payer requirements based on opioid prescribing guidelines and provide recommendations for addressing them.
If you had a “magic wand,” what would you change in the health system to improve care for patients with pain?

What it will inform

The session and content gathered will inform the creation of a person-centered pain management journey map—a visual illustration of a chronic pain management journey—that will serve to accelerate the uptake of a range of pain treatments by outlining approaches to effective communication that lead to strong clinical relationships and optimal quality of life for people with pain.

Disclaimer

The views expressed in this listening session are those of the participants and not necessarily of the participants’ organizations, the National Academy of Medicine (NAM), or the National Academies of Sciences, Engineering, and Medicine (the National Academies.)

If you have any questions, please contact us at opioidcollaborative@nas.edu

Contact

Elizabeth Finkelman

opioidcollaborative@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webinar

Action Collaborative on Countering the U.S. Opioid Epidemic Webinar

February 13, 2019

4:00 PM - 5:00 PM (EST)

Past

About

Join the National Academy of Medicine on February 13, 2019 for a webinar featuring an overview of the Action Collaborative on Countering the U.S. Opioid Epidemic and the work it will undertake over the next two years to share knowledge, align initiatives, and advance multisector solutions to improve outcomes for those impacted by the opioid epidemic.

Day/Time: February 13, 2019, 4:00 – 5:00pm EST

Every day, an estimated 130 Americans die from an opioid overdose – a grim statistic that has devastated families and communities around the nation. Due to the complex and urgent nature of the epidemic, reversing the opioid crisis will require a multi-sectoral and multi-pronged response; no organization, government agency, or sector can solve this crisis on its own. Within the past year alone, numerous initiatives, reports, guidelines, and recommendations have been developed to address the epidemic across the public and private sectors. With so much activity underway, strong mechanisms to support better coordination, information-sharing, and evidence-based practice are needed.

To improve coordination and accelerate the pace of change, the National Academy of Medicine has partnered with the Aspen Institute and more than 50 other organizations to form an Action Collaborative on Countering the U.S. Opioid Epidemic.

Join the NAM for a one-hour webinar that will introduce this one-of-a-kind public-private partnership that comprises government, communities, health systems, provider groups, payers, industry, nonprofits, academia, and more. An overview of the Action Collaborative will be followed by updates from the leads of the Action Collaborative’s four working groups. The webinar will end with approximately 20 minutes for questions and answers with the listening audience.

Webinar Agenda

Introductions and Welcome – Victor Dzau, President, National Academy of Medicine and Action Collaborative Co-Chair

Overview of the Action Collaborative – ADM Brett Giroir, Assistant Secretary for Health, U.S. Department of Health and Human Services and Action Collaborative Co-Chair

Presentations of the Action Collaborative Working Groups

Health Professional Education and Training – Steve Singer, Vice President, Education and Outreach, Accreditation Council for Continuing Medical Education

Opioid Prescribing Guidelines and Evidence Standards – Helen Burstin, Executive Vice President and Chief Executive Officer, Council of Medical Specialty Societies

Prevention, Treatment, and Recovery from Opioid Use Disorders – Alonzo Plough, Chief Science Officer and Vice President, Research-Evaluation-Learning, Robert Wood Johnson Foundation

Research, Data, and Metrics – Kelly Clark, President, American Society of Addiction Medicine

Q&A with webinar audience

Contact

Jarrett Nguyen

opioidcollaborative@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Meeting #1 - Action Collaborative on Countering the U.S. Opioid Epidemic

July 27, 2018

8:00 AM - 4:00 PM (EDT)

Past

About

Agenda

Open Session

8:00 am | Opening Remarks

Victor J. Dzau, National Academy of Medicine
Ruth Katz, Aspen Institute
Jonathan Perlin, HCA Healthcare

8:10 am | Special Address

ADM Brett Giroir, Assistant Secretary for Health, U.S. Department of Health and Human Services

8:40 am | Meeting Objectives

Victor J. Dzau, National Academy of Medicine

Closed Session (invited participants only)

8:45 am to 4:00 pm | Presentations and Discussion

Contact

Elizabeth Finkelman

opioidcollaborative@nas.edu

Location

National Academy of Sciences Building

2101 Constitution Ave NW

Washington DC 20418, USA

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Action Collaborative on Combatting Substance Use and Opioid Crises

Dropdown items

Caring for Patients with Chronic Pain: Perspectives from Clinicians | Listening Session

Caring for Patients with Chronic Pain: Perspectives from Clinicians

Action Collaborative on Countering the U.S. Opioid Epidemic Webinar

Meeting #1 - Action Collaborative on Countering the U.S. Opioid Epidemic